Skip to main content
. 2021 Nov 6;225(6):1021–1031. doi: 10.1093/infdis/jiab567

Figure 2.

Figure 2.

Antibody responses to PCV-10 and PPV-23 administered antepartum or postpartum. Data were derived from 336 women with HIV randomly assigned to PCV-10 antepartum (n = 115), PPV-23 antepartum (n = 115), PCV-10 postpartum (n = 53), and PPV-23 postpartum (n = 53). The following serotypes showed significant differences (P ≤ .03) in the unadjusted nonparametric comparison of week 4 postvaccination antibody concentrations antepartum versus postpartum: 1, PCV-10 and PPV-23; 4, PCV-10 and PPV-23; 5, PCV-10 and PPV-23; 7F, PPV-23; 14, PPV-23; 23F, PPV-23; and 33F, PPV-23. The following serotypes showed significant differences in the unadjusted comparison of PCV-10 versus PPV-23 antibody concentrations at 4 weeks after vaccination: 1, antepartum and postpartum; 4, antepartum and postpartum; 7F, postpartum; and 14, postpartum. Maternal geometric means and 95% confidence intervals are shown.